The etiology of hypertension in the metabolic syndrome part two: The gene-environment interaction

Current Vascular Pharmacology

Volumn 4, Issue 4, 2006, Pages 305-320

  Sharma, Vijay ^a   McNeill, John H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; CHOLECYSTOKININ; FATTY ACID; GHRELIN; GLUCOCORTICOID; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LEPTIN; PEPTIDE YY; PHOSPHOENOLPYRUVATE CARBOXYLASE; POLYUNSATURATED FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

CARDIOVASCULAR RISK; ENVIRONMENTAL FACTOR; FOOD INTAKE; GENETIC ANALYSIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAGNESIUM DEFICIENCY; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; REVIEW; SLEEP APNEA SYNDROME; ANIMAL; BLOOD; CLIMATE; DIET; EVOLUTION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHENOTYPE; STRESS;

ANIMALS; CLIMATE; DIET; EVOLUTION; FATTY ACIDS, NONESTERIFIED; HUMANS; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; PHENOTYPE; SLEEP APNEA SYNDROMES; STRESS;

EID: 34248993876     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016106778521661     Document Type: Review

References (236)

1. Pickering GW. The nature of essential hypertension. Lancet 1959; 2: 1027-28.
2. Khoury MJ, Adams MJ, Jr., Flanders WD. An epidemiologic approach to ecogenetics. Am J Hum Genet 1988; 42(1): 89-95.
3. Lane DA, Lip GY. Ethnic differences in hypertension and blood pressure control in the UK. QJM 2001; 94(7): 391-6.
4. Young JH, Parler P, Bristol B, Klag MJ. The coming epidemic: hypertension in rural Kyrgyzstan, Central Asia. J Hum Hypertens 2005; 19(2): 145-8.
5. Tomson J, Lip GY. Blood pressure demographics: nature or nurture ... ... genes or environment? BMC Med 2005; 3(1): 3.
6. Cooper RS, Wolf-Maier K, Luke A, Adeyemo A, Banegas JR, Forrester T, et al. An international comparative study of blood pressure in populations of European vs. African descent. BMC Med 2005; 3(1): 2.
7. Poulter N, Khaw KT, Hopwood BE, Mugambi M, Peart WS, Rose G, et al. Blood pressure and associated factors in a rural Kenyan community. Hypertension 1984; 6(6 Pt 1): 810-3.
8. Mann GV, Roels OA, Price DL, Merrill JM. Cardiovascular disease in African Pygmies. A survey of the health status, serum lipids and diet of Pygmies in Congo. J Chronic Dis 1962; 15: 341-71.
9. Mann GV, Shafer RD, Anderson RS, Stansted HH. Cardiovascular disease in the Masai. J Atheroscl Res 1962; 4: 289-312.
10. Poulter N, Khaw KT, Hopwood BE, Mugambi M, Peart WS, Sever PS. Salt and blood pressure in various populations. J Cardiovasc Pharmacol 1984; 6 (Suppl 1): S197-203.
11. Beaglehole R, Salmond CE, Hooper A, Huntsman J, Stanhope JM, Cassel JC, et al. Blood pressure and social interaction in Tokelauan migrants in New Zealand. J Chronic Dis 1977; 30(12): 803-12.
12. Poulter NR, Khaw KT, Hopwood BE, Mugambi M, Peart WS, Rose G, et al. The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. Bmj 1990; 300(6730): 967-72.
13. Lewontin RC. The apportionment of human diversity. Evolutionary Biology 1972;6:381-398.
14. Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic. Hypertension 2001; 37(2 Part 2): 739-43.
15. Stavroulakis GA, Makris TK, Krespi PG, Hatzizacharias AN, Gialeraki AE, Anastasiadis G, et al. Predicting response to chronic antihypertensive treatment with fosinopril: the role of angiotensin-converting enzyme gene polymorphism. Cardiovasc Drugs Ther 2000; 14(4): 427-32.
16. Ohmichi N, Iwai N, Uchida Y, Shichiri G, Nakamura Y, Kinoshita M. Relationship between the response to the angiotensin converting enzyme inhibitor imidapril and the angiotensin converting enzyme genotype. Am J Hypertens 1997; 10(8): 951-5.
17. Tanira MO, Al Balushi KA. Genetic variations related to hypertension: a review. J Hum Hypertens 2005; 19(1): 7-19.
18. Timberlake DS, O'Connor DT, Parmer RJ. Molecular genetics of essential hypertension: recent results and emerging strategies. Curr Opin Nephrol Hypertens 2001; 10(1): 71-9.
19. Tabor HK, Risch NJ, Myers RM. Opinion: Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002;3(5):391-7.
20. Maes HH, Neale MC, Eaves LJ. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 1997; 27(4): 325-51.
21. Foundation BN. Obesity. Report of the BNF TaskForce. Oxford: Blackwell; 1999.
22. Kue Young T, Chateau D, Zhang M. Factor analysis of ethnic variation in the multiple metabolic (insulin resistance) syndrome in three Canadian populations. Am J Hum Biol 2002; 14(5): 649-58.
23. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287(3): 356-9.
24. Deurenberg-Yap M, Li T, Tan WL, van Staveren WA, Chew SK, Deurenberg P. Can dietary factors explain differences in serum cholesterol profiles among different ethnic groups (Chinese, Malays and Indians) in Singapore? Asia Pac J Clin Nutr 2001; 10(1): 39-45.
25. Cutter J, Tan BY, Chew SK. Levels of cardiovascular disease risk factors in Singapore following a national intervention programme. Bull World Health Organ 2001; 79(10): 908-15.
26. Araneta MR, Wingard DL, Barrett-Connor E. Type 2 diabetes and metabolic syndrome in Filipina-American women : a high-risk nonobese population. Diabetes Care 2002; 25(3): 494-9.
27. Chagnon YC, Perusse L, Weisnagel SJ, Rankinen T, Bouchard C. The human obesity gene map: the 1999 update. Obes Res 2000; 8(1): 89-117.
28. Clement K, Philippi A, Jury C, Pividal R, Hager J, Demenais F, et al. Candidate gene approach of familial morbid obesity: linkage analysis of the glucocorticoid receptor gene. Int J Obes Relat Metab Disord 1996; 20(6): 507-12.
29. Ochoa Mdel C, Marti A, Martinez JA. [Obesity studies in candidate genes]. Med Clin (Barc) 2004; 122(14): 542-51.
30. Patti ME. Gene expression in humans with diabetes and prediabetes: what have we learned about diabetes pathophysiology? Curr Opin Clin Nutr Metab Care 2004; 7(4): 383-90.
31. Pedersen O, Echwald SM. Genetics of human obesity. In: Olefsky JM, editor. Diabetes mellitus. A fundamental and clinical text. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2004. pp. 827-838.
32. Barsh GS, Farooqi IS, O'Rahilly S. Genetics of body-weight regulation. Nature 2000; 404(6778): 644-51.
33. Prentice AM. Obesity and its potential mechanistic basis. Br Med Bull 2001; 60: 51-67.
34. O'Rahilly S, Barroso I, Wareham NJ. Genetic factors in type 2 diabetes: the end of the beginning? Science 2005; 307(5708): 370-3.
35. Allison DB, Weber MT. Treatment and prevention of obesity: what works, what doesn't work, and what might work. Lipids 2003; 38(2): 147-55.
36. Hall JE, Brands MW, Dixon WN, Smith MJ, Jr. Obesity-induced hypertension. Renal function and systemic hemodynamics. Hypertension 1993; 22(3): 292-9.
37. Carroll JF, Huang M, Hester RL, Cockrell K, Mizelle HL. Hemodynamic alterations in hypertensive obese rabbits. Hypertension 1995; 26(3): 465-70.
38. Rocchini AP, Mao HZ, Babu K, Marker P, Rocchini AJ. Clonidine prevents insulin resistance and hypertension in obese dogs. Hypertension 1999; 33(1 Pt 2): 548-53.
39. Jones DW, Kim JS, Andrew ME, Kim SJ, Hong YP. Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey. J Hypertens 1994; 12(12): 1433-7.
40. Garrison RJ, Kannel WB, Stokes J, 3rd, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 1987; 16(2): 235-51.
41. Berchtold P, Jorgens V, Finke C, Berger M. Epidemiology of obesity and hypertension. Int J Obes 1981; 5 (Suppl 1): 1-7.
42. Guyton AC. The surprising kidney-fluid mechanism for pressure control - its infinite gain! Hypertension 1990; 16(6): 725-30.
43. Julius S, Valentini M, Palatini P. Overweight and hypertension : a 2-way street? Hypertension 2000; 35(3): 807-13.
44. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 97(11): 2601-10.
45. Hennes MM, O'Shaughnessy IM, Kelly TM, LaBelle P, Egan BM, Kissebah AH. Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system. Hypertension 1996; 28(1): 120-6.
46. Pouliot MC, Despres JP, Nadeau A, Moorjani S, Prud'Homme D, Lupien PJ, et al. Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 1992; 41(7): 826-34.
47. Montague CT, O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 2000; 49(6): 883-8.
48. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, Sovijarvi A, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87(7): 3023-8.
49. Benthem L, Kuipers F, Steffens AB, Scheurink AJ. Excessive portal venous supply of long-chain free fatty acids to the liver, leading to hypothalamus-pituitary-adrenal-axis and sympathetic activation as a key to the development of syndrome X. A proposed concept for the induction of syndrome X. Ann N Y Acad Sci 1999; 892: 308-11.
50. Manzella D, Barbieri M, Rizzo MR, Ragno E, Passariello N, Gambardella A, et al. Role of free fatty acids on cardiac autonomic nervous system in noninsulin-dependent diabetic patients: effects of metabolic control. J Clin Endocrinol Metab 2001; 86(6): 2769-74.
51. Bjorntorp PA. Overweight is risking fate. Baillieres Best Pract Res Clin Endocrinol Metab 1999; 13(1): 47-69.
52. Getty L, Panteleon AE, Mittelman SD, Dea MK, Bergman RN. Rapid oscillations in omental lipolysis are independent of changing insulin levels in vivo. J Clin Invest 2000; 106(3): 421-30.
53. Hucking K, Hamilton-Wessler M, Ellmerer M, Bergman RN. Burst-like control of lipolysis by the sympathetic nervous system in vivo. J Clin Invest 2003; 111(2): 257-64.
54. Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, Dea MK, et al. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab 2005; 288(2): E454-61.
55. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307(5708): 426-30.
56. Bouchard C. Genetic determinants of regional fat distribution. Hum Reprod 1997; 12 (Suppl 1): 1-5.
57. Bjorntorp P. Heart and soul: stress and the metabolic syndrome. Scand Cardiovasc J 2001; 35(3): 172-7.
58. Clarke SD. Polyunsaturated fatty acid regulation of gene transcription: a mechanism to improve energy balance and insulin resistance. Br J Nutr 2000; 83 (Suppl 1): S59-66.
59. Bray GA, Lovejoy JC, Smith SR, DeLany JP, Lefevre M, Hwang D, et al. The influence of different fats and fatty acids on obesity, insulin resistance and inflammation. J Nutr 2002; 132(9): 2488-91.
60. Bray GA, Paeratakul S, Popkin BM. Dietary fat and obesity: a review of animal, clinical and epidemiological studies. Physiol Behav 2004; 83(4): 549-55.
61. Hu FB, van Dam RM, Liu S. Diet and risk of Type II diabetes: the role of types of fat and carbohydrate. Diabetologia 2001; 44(7): 805-17.
62. Gil-Campos M, Canete RR, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 2004; 23(5): 963-74.
63. Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. Cmaj 2005; 172(7): 899-905.
64. Zammit VA, Waterman IJ, Topping D, McKay G. Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J Nutr 2001; 131(8): 2074-7.
65. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785-9.
66. Ruderman NB, Saha AK, Vavvas D, Witters LA. Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol 1999; 276(1 Pt 1): E1-E18.
67. Ruderman NB, Saha AK, Kraegen EW. Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology 2003; 144(12): 5166-71.
68. Bakker SJ, Gans RO, ter Maaten JC, Teerlink T, Westerhoff HV, Heine RJ. The potential role of adenosine in the pathophysiology of the insulin resistance syndrome. Atherosclerosis 2001; 155(2): 283-90.
69. Soboll S, Seitz HJ, Sies H, Ziegler B, Scholz R. Effect of long-chain fatty acyl-CoA on mitochondrial and cytosolic ATP/ADP ratios in the intact liver cell. Biochem J 1984; 220(2): 371-6.
70. Grill V, Qvigstad E. Fatty acids and insulin secretion. Br J Nutr 2000; 83 (Suppl 1): S79-84.
71. Kohen-Avramoglu R, Theriault A, Adeli K. Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia. Clin Biochem 2003; 36(6): 413-20.
72. Ravussin E, Smith SR. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci 2002; 967: 363-78.
73. Prentice AM, Black AE, Coward WA, Davies HL, Goldberg GR, Murgatroyd PR, et al. High levels of energy expenditure in obese women. Br Med J (Clin Res Ed) 1986; 292(6526): 983-7.
74. Prentice AM, Black AE, Coward WA, Cole TJ. Energy expenditure in overweight and obese adults in affluent societies: an analysis of 319 doubly-labelled water measurements. Eur J Clin Nutr 1996; 50(2): 93-7.
75. Ravussin E, Lillioja S, Knowler WC, Christin L, Freymond D, Abbott WG, et al. Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 1988; 318(8): 467-72.
76. Astrup A, Buemann B, Toubro S, Raben A. Defects in substrate oxidation involved in the predisposition to obesity. Proc Nutr Soc 1996; 55(3): 817-28.
77. Wade AJ, Marbut MM, Round JM. Muscle fibre type and aetiology of obesity. Lancet 1990; 335(8693): 805-8.
78. Astrup A, Buemann B, Christensen NJ, Toubro S. Failure to increase lipid oxidation in response to increasing dietary fat content in formerly obese women. Am J Physiol 1994; 266(4 Pt 1): E592-9.
79. Thompson CH, Sanderson AL, Sandeman D, Stein C, Borthwick A, Radda GK, et al. Fetal growth and insulin resistance in adult life: role of skeletal muscle morphology. Clin Sci (Lond) 1997; 92(3): 291-6.
80. Phillips DI, Caddy S, Ilic V, Fielding BA, Frayn KN, Borthwick AC, et al. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 1996; 45(8): 947-50.
81. Flatt JP. Importance of nutrient balance in body weight regulation. Diabetes Metab Rev 1988; 4(6): 571-81.
82. Holst B, Schwartz TW. Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation. Trends Pharmacol Sci 2004; 25(3): 113-7.
83. Korner J, Leibel RL. To eat or not to eat - how the gut talks to the brain. N Engl J Med 2003; 349(10): 926-8.
84. Klein S, Coppack SW, Mohamed-Ali V, Landt M. Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 1996; 45(7): 984-7.
85. Flier JS. Clinical review 94: What's in a name? In search of leptin's physiologic role. J Clin Endocrinol Metab 1998; 83(5): 1407-13.
86. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372(6505): 425-32.
87. Janeckova R. The role of leptin in human physiology and pathophysiology. Physiol Res 2001; 50(5): 443-59.
88. Moran O, Phillip M. Leptin: obesity, diabetes and other peripheral effects - a review. Pediatr Diabetes 2003; 4(2): 101-9.
89. Baratta M. Leptin - from a signal of adiposity to a hormonal mediator in peripheral tissues. Med Sci Monit 2002; 8(12): RA282-92.
90. Bagnasco M, Kalra PS, Kalra SP. Ghrelin and leptin pulse discharge in fed and fasted rats. Endocrinology 2002; 143(2): 726-9.
91. De Ambrogi M, Volpe S, Tamanini C. Ghrelin: central and peripheral effects of a novel peptydil hormone. Med Sci Monit 2003; 9(9): RA217-24.
92. Bates SH, Kulkarni RN, Seifert M, Myers MG. Roles for leptin receptor/STAT-3-dependent and -independent signals in the regulation of glucose homeostasis. Cell Metabolism 2005; 1: 169-178.
93. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17(2): 151-83.
94. Prentice AM, Jebb SA. Obesity in Britain: gluttony or sloth? BMJ 1995; 311(7002): 437-9.
95. Gross LS, Li L, Ford ES, Liu S. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr 2004; 79(5): 774-9.
96. Putnam JJ, Allshouse JE. Food consumption, prices and expenditure 1970-97. Stat Bulletin: Economic Research Service, US Department of Agriculture; 1999.
97. Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. Jama 1997; 277(6): 472-7.
98. Parilo M. Effect of a low fat diet on carbohydrate metabolism in patients with hypertension. Hypertension 1988; 22: 244-8.
99. Reaven GM. Do high carbohydrate diets prevent the development or attenuate the manifestations (or both) of syndrome X? A viewpoint strongly against. Curr Opin Lipidol 1997; 8(1): 23-7.
100. Grollman A. The Cardiac Output of Man in Health and Disease. 1st ed. Springfield, Illinois: Charles C. Thomas; 1932.
101. Dahl LK. Effects of chronic excess salt feeding. Induction of self-sustaining hypertension in rats. J Exp Med 1961; 114: 231-6.
102. Hall CE, Hall O. Salt Hypertension: Facilitated Induction in Two Rat Strains. Tex Rep Biol Med 1964; 22: 529-49.
103. Hall CE, Hall O. Augmented Salt Ingestion and Its Effect Upon Salt Hypertension and Adrenal-Regeneration Hypertension. Lab Invest 1964; 13: 1471-83.
104. Hall CE, Hall O. Comparative ability of certain sugars and honey to enhance saline polydipsia and salt hypertension. Proc Soc Exp Biol Med 1966; 122(2): 362-5.
105. Ahrens RA, Demuth P, Lee MK, Majkowski JW. Moderate sucrose ingestion and blood pressure in the rat. J Nutr 1980; 110(4): 725-31.
106. Preuss MB, Preuss HG. The effects of sucrose and sodium on blood pressures in various substrains of Wistar rats. Lab Invest 1980; 43(2): 101-7.
107. Srinivasan SR, Berenson GS, Radhakrishnamurthy B, Dalferes ER, Jr., Underwood D, Foster TA. Effects of dietary sodium and sucrose on the induction of hypertension in spider monkeys. Am J Clin Nutr 1980; 33(3): 561-9.
108. Walker A, Ahrens R. Sucrose, hypertension and heart disease. The Am J Clin Nut 1975; 28: 195-202.
109. Young JB, Landsberg L. Stimulation of the sympathetic nervous system during sucrose feeding. Nature 1977; 269(5629): 615-7.
110. Bunag RD, Tomita T, Sasaki S. Chronic sucrose ingestion induces mild hypertension and tachycardia in rats. Hypertension 1983; 5(2): 218-25.
111. Sleder J, Chen YD, Cully MD, Reaven GM. Hyperinsulinemia in fructose-induced hypertriglyceridemia in the rat. Metabolism 1980; 29(4): 303-5.
112. Zavaroni I, Sander S, Scott S, Reaven GM. Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism 1980; 29(10): 970-3.
113. Wright DW, Hansen RI, Mondon CE, Reaven GM. Sucrose-induced insulin resistance in the rat: modulation by exercise and diet. Am J Clin Nutr 1983; 38(6): 879-83.
114. Reaven GM, Ho H, Hoffman BB. Attenuation of fructose-induced hypertension in rats by exercise training. Hypertension 1988; 12(2): 129-32.
115. Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987; 10(5): 512-6.
116. Reaven GM, Ho H, Hoffmann BB. Somatostatin inhibition of fructose-induced hypertension. Hypertension 1989; 14(2): 117-20.
117. Thresher JS, Podolin DA, Wei Y, Mazzeo RS, Pagliassotti MJ. Comparison of the effects of sucrose and fructose on insulin action and glucose tolerance. Am J Physiol Regul Integr Comp Physiol 2000; 279(4): R1334-40.
118. Verma S, Bhanot S, McNeill JH. Sympathectomy prevents fructose-induced hyperinsulinemia and hypertension. Eur J Pharmacol 1999; 373(2-3): R1-4.
119. Penicaud L, Berthault MF, Morin J, Dubar M, Ktorza A, Ferre P. Rilmenidine normalizes fructose-induced insulin resistance and hypertension in rats. J Hypertens Suppl 1998; 16(3): S45-9.
120. Verma S, Bhanot S, Yao L, McNeill JH. Defective endothelium-dependent relaxation in fructose-hypertensive rats. Am J Hypertens 1996; 9(4 Pt 1): 370-6.
121. Tobey TA, Mondon CE, Zavaroni I, Reaven GM. Mechanism of insulin resistance in fructose-fed rats. Metabolism 1982; 31(6): 608-12.
122. Bizeau ME, Thresher JS, Pagliassotti MJ. A high-sucrose diet increases gluconeogenic capacity in isolated periportal and perivenous rat hepatocytes. Am J Physiol Endocrinol Metab 2001; 280(5): E695-702.
123. Tuovinen CG, Bender AE. Some metabolic effects of prolonged feeding of starch, sucrose, fructose and carbohydrate-free diet in the rat. Nutr Metab 1975; 19(3-4): 161-72.
124. Blakely SR, Hallfrisch J, Reiser S, Prather ES. Long-term effects of moderate fructose feeding on glucose tolerance parameters in rats. J Nutr 1981; 111(2): 307-14.
125. Rawana S, Clark K, Zhong S, Buison A, Chackunkal S, Jen KL. Low dose fructose ingestion during gestation and lactation affects carbohydrate metabolism in rat dams and their offspring. J Nutr 1993; 123(12): 2158-65.
126. Thorburn AW, Storlien LH, Jenkins AB, Khouri S, Kraegen EW. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr 1989; 49(6): 1155-63.
127. Bezerra RM, Ueno M, Silva MS, Tavares DQ, Carvalho CR, Saad MJ. A high fructose diet affects the early steps of insulin action in muscle and liver of rats. J Nutr 2000; 130(6): 1531-5.
128. Wei Y, Pagliassotti MJ. Hepatospecific effects of fructose on c-jun NH2-terminal kinase: implications for hepatic insulin resistance. Am J Physiol Endocrinol Metab 2004; 287(5): E926-33.
129. Kelley GL, Allan G, Azhar S. High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology 2004; 145(2): 548-55.
130. Ling PR, Mueller C, Smith RJ, Bistrian BR. Hyperglycemia induced by glucose infusion causes hepatic oxidative stress and systemic inflammation, but not STAT3 or MAP kinase activation in liver in rats. Metabolism 2003; 52(7): 868-74.
131. Sener A, Malaisse WJ. Environmental modulation of D-fructose insulinotropic action. Acta Diabetol 1998; 35(2): 74-6.
132. Grant AM, Christie MR, Ashcroft SJ. Insulin release from human pancreatic islets in vitro. Diabetologia 1980; 19(2): 114-7.
133. Curry DL. Effects of mannose and fructose on the synthesis and secretion of insulin. Pancreas 1989; 4(1): 2-9.
134. Zakim D. The effect of fructose on hepatic synthesis of fatty acids. Acta Med Scand Suppl 1972; 542: 205-14.
135. Mayes PA. Intermediary metabolism of fructose. Am J Clin Nutr 1993; 58(5 Suppl): 754S-765S.
136. Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 2002; 76(5): 911-22.
137. Balon TW, Jasman A, Scott S, Meehan WP, Rude RK, Nadler JL. Dietary magnesium prevents fructose-induced insulin insensitivity in rats. Hypertension 1994; 23(6 Pt 2): 1036-9.
138. Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 1993; 21(6 Pt 2): 1024-9.
139. Dirlewanger M, Schneiter P, Jequier E, Tappy L. Effects of fructose on hepatic glucose metabolism in humans. Am J Physiol Endocrinol Metab 2000; 279(4): E907-11.
140. Dai S, Todd ME, Lee S, McNeill JH. Fructose loading induces cardiovascular and metabolic changes in nondiabetic and diabetic rats. Can J Physiol Pharmacol 1994; 72(7): 771-81.
141. Galipeau D, Arikawa E, Sekirov I, McNeill JH. Chronic thromboxane synthase inhibition prevents fructose-induced hypertension. Hypertension 2001; 38(4): 872-6.
142. Song D, Arikawa E, Galipeau D, Battell M, McNeill JH. Androgens are necessary for the development of fructose-induced hypertension. Hypertension 2004; 43(3): 667-72.
143. D'Angelo G, Elmarakby AA, Pollock DM, Stepp DW. Fructose feeding increases insulin resistance but not blood pressure in Sprague-Dawley rats. Hypertension 2005; 46(4): 806-11.
144. Rupp H, Maisch B. Radiotelemetric characterization of overweight-associated rises in blood pressure and heart rate. Am J Physiol 1999; 277(4 Pt 2): H1540-5.
145. Astrup A, Toubro S, Raben A, Skov AR. The role of low-fat diets and fat substitutes in body weight management: what have we learned from clinical studies? J Am Diet Assoc 1997; 97(7 Suppl): S82-7.
146. Lawton CL, Burley VJ, Wales JK, Blundell JE. Dietary fat and appetite control in obese subjects: weak effects on satiation and satiety. Int J Obes Relat Metab Disord 1993; 17(7): 409-16.
147. Flatt JP, Ravussin E, Acheson KJ, Jequier E. Effects of dietary fat on postprandial substrate oxidation and on carbohydrate and fat balances. J Clin Invest 1985; 76(3): 1019-24.
148. Hill JO, Peters JC, Reed GW, Schlundt DG, Sharp T, Greene HL. Nutrient balance in humans: effects of diet composition. Am J Clin Nutr 1991; 54(1): 10-7.
149. Abbott WG, Howard BV, Christin L, Freymond D, Lillioja S, Boyce VL, et al. Short-term energy balance: relationship with protein, carbohydrate, and fat balances. Am J Physiol 1988; 255(3 Pt 1): E332-7.
150. Thomas CD, Peters JC, Reed GW, Abumrad NN, Sun M, Hill JO. Nutrient balance and energy expenditure during ad libitum feeding of high-fat and high-carbohydrate diets in humans. Am J Clin Nutr 1992; 55(5): 934-42.
151. Blundell JE, Macdiarmid JI. Passive overconsumption. Fat intake and short-term energy balance. Ann N Y Acad Sci 1997; 827: 392-407.
152. Sparti A, Windhauser MM, Champagne CM, Bray GA. Effect of an acute reduction in carbohydrate intake on subsequent food intake in healthy men. Am J Clin Nutr 1997; 66(5): 1144-50.
153. Tremblay A, Lavallee N, Almeras N, Allard L, Despres JP, Bouchard C. Nutritional determinants of the increase in energy intake associated with a high-fat diet. Am J Clin Nutr 1991; 53(5): 1134-7.
154. Green SM, Blundell JE. Effect of fat- and sucrose-containing foods on the size of eating episodes and energy intake in lean dietary restrained and unrestrained females: potential for causing overconsumption. Eur J Clin Nutr 1996; 50(9): 625-35.
155. Bray GA, Popkin BM. Dietary fat intake does affect obesity! Am J Clin Nutr 1998; 68(6): 1157-73.
156. Curb JD, Marcus EB. Body fat and obesity in Japanese Americans. Am J Clin Nutr 1991; 53(6 Suppl): 1552S-1555S.
157. Sonne-Holm S, Sorensen TI. Post-war course of the prevalence of extreme overweight among Danish young men. J Chronic Dis 1977; 30(6): 351-8.
158. Price RA, Charles MA, Pettitt DJ, Knowler WC. Obesity in Pima Indians: large increases among post-World War II birth cohorts. Am J Phys Anthropol 1993; 92(4): 473-9.
159. Popkin BM, Paeratakul S, Zhai F, Ge K. Dietary and environmental correlates of obesity in a population study in China. Obes Res 1995; 3 Suppl 2: 135s-143s.
160. Paeratakul S, Popkin BM, Keyou G, Adair LS, Stevens J. Changes in diet and physical activity affect the body mass index of Chinese adults. Int J Obes Relat Metab Disord 1998; 22(5): 424-31.
161. Lissner L, Heitmann BL. Dietary fat and obesity: evidence from epidemiology. Eur J Clin Nutr 1995; 49(2): 79-90.
162. Roy J, Lovejoy J, Windhauser M, Bray G. Metabolic effects of fat substitution with Olestra. FASEB J 1997; 11: A358.
163. Meredith IT, Friberg P, Jennings GL, Dewar EM, Fazio VA, Lambert GW, et al. Exercise training lowers resting renal but not cardiac sympathetic activity in humans. Hypertension 1991; 18(5): 575-82.
164. Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas AM, Schroll M. Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. Stroke 1995; 26(3): 361-7.
165. Donaldson GC, Robinson D, Allaway SL. An analysis of arterial disease mortality and BUPA health screening data in men, in relation to outdoor temperature. Clin Sci (Lond) 1997; 92(3): 261-8.
166. Gyllerup S, Lanke J, Lindholm LH, Schersten B. Cold climate is an important factor in explaining regional differences in coronary mortality even if serum cholesterol and other established risk factors are taken into account. Scott Med J 1993; 38(6): 169-72.
167. Rostand SG. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 1997; 30(2 Pt 1): 150-6.
168. Schum JL, Jorgensen RS, Verhaeghen P, Sauro M, Thibodeau R. Trait anger, anger expression, and ambulatory blood pressure: a meta-analytic review. J Behav Med 2003; 26(5): 395-415.
169. Everson SA, Kaplan GA, Goldberg DE, Salonen R, Salonen JT. Hopelessness and 4-year progression of carotid atherosclerosis. The Kuopio Ischemic Heart Disease Risk Factor Study. Arterioscler Thromb Vasc Biol 1997; 17(8): 1490-5.
170. Hippisley-Cox J, Fielding K, Pringle M. Depression as a risk factor for ischaemic heart disease in men: population based case-control study. BMJ 1998; 316(7146): 1714-9.
171. Everson SA, Roberts RE, Goldberg DE, Kaplan GA. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med 1998; 158(10): 1133-8.
172. Whiteman MC, Deary IJ, Lee AJ, Fowkes FG. Submissiveness and protection from coronary heart disease in the general population: Edinburgh Artery Study. Lancet 1997; 350(9077): 541-5.
173. Henry JP, Grim CE. Psychosocial mechanisms of primary hypertension. J Hypertens 1990; 8(9): 783-93.
174. Henry JP, Stephens PM. Stress, health and the psychosocial environment: a sociobiological approach to medicine. New York, Heidelberg, Berlin: Springer Verlag; 1977.
175. Kopp MS, Rethelyi J. Where psychology meets physiology: chronic stress and premature mortality - the Central-Eastern European health paradox. Brain Res Bull 2004; 62(5): 351-67.
176. Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364(9438): 953-62.
177. Lynch JW, Everson SA, Kaplan GA, Salonen R, Salonen JT. Does low socioeconomic status potentiate the effects of heightened cardiovascular responses to stress on the progression of carotid atherosclerosis? Am J Public Health 1998; 88(3): 389-94.
178. Stronks K, van de Mheen HD, Looman CW, Mackenbach JP. Cultural, material, and psychosocial correlates of the socioeconomic gradient in smoking behavior among adults. Prev Med 1997; 26(5 Pt 1): 754-66.
179. Colhoun HM, Hemingway H, Poulter NR. Socio-economic status and blood pressure: an overview analysis. J Hum Hypertens 1998; 12(2): 91-110.
180. Marmot MG, Bosma H, Hemingway H, Brunner E, Stansfeld S. Contribution of job control and other risk factors to social variations in coronary heart disease incidence. Lancet 1997; 350(9073): 235-9.
181. Curtis AB, James SA, Raghunathan TE, Alcser KH. Job strain and blood pressure in African Americans: the Pitt County Study. Am J Public Health 1997; 87(8): 1297-302.
182. Kamarck TW, Shiffman SM, Smithline L, Goodie JL, Paty JA, Gnys M, et al. Effects of task strain, social conflict, and emotional activation on ambulatory cardiovascular activity: daily life consequences of recurring stress in a multiethnic adult sample. Health Psychol 1998; 17(1): 17-29.
183. Steptoe A, Evans O, Fieldman G. Perceptions of control over work: psychophysiological responses to self-paced and externally-paced tasks in an adult population sample. Int J Psychophysiol 1997; 25(3): 211-20.
184. Hallqvist J, Diderichsen F, Theorell T, Reuterwall C, Ahlbom A. Is the effect of job strain on myocardial infarction risk due to interaction between high psychological demands and low decision latitude? Results from Stockholm Heart Epidemiology Program (SHEEP). Soc Sci Med 1998; 46(11): 1405-15.
185. Williams RB, Barefoot JC, Blumenthal JA, Helms MJ, Luecken L, Pieper CF, et al. Psychosocial correlates of job strain in a sample of working women. Arch Gen Psychiatry 1997; 54(6): 543-8.
186. Peter R, Siegrist J. Chronic work stress, sickness absence, and hypertension in middle managers: general or specific sociological explanations? Soc Sci Med 1997; 45(7): 1111-20.
187. Bosma H, Peter R, Siegrist J, Marmot M. Two alternative job stress models and the risk of coronary heart disease. Am J Public Health 1998; 88(1): 68-74.
188. Timio M, Lippi G, Venanzi S, Gentili S, Quintaliani G, Verdura C, et al. Blood pressure trend and cardiovascular events in nuns in a secluded order: a 30-year follow-up study. Blood Press 1997; 6(2): 81-7.
189. Vogele C, Jarvis A, Cheeseman K. Anger suppression, reactivity, and hypertension risk: gender makes a difference. Ann Behav Med 1997; 19(1): 61-9.
190. Melamed S, Kristal-Boneh E, Froom P, Harari G, Green MS, Ribak J. Pressure response to successive clinic readings predicts an elevated blood pressure at 2.6 years' follow-up: the Israeli CORDIS Study. Cardiovascular Occupational Risk Factor Determination in Israeli Industries. J Hum Hypertens 1997; 11(2): 101-6.
191. Markovitz JH, Raczynski JM, Wallace D, Chettur V, Chesney MA.
192. Steptoe A. Psychological factors and cardiovascular disease. Clin Psychol Behav Med 2003; 11: 655.
193. Ordunez-Garcia PO, Espinosa-Brito AD, Cooper RS, Kaufman JS, Nieto FJ. Hypertension in Cuba: evidence of a narrow black-white difference. J Hum Hypertens 1998; 12(2): 111-6.
194. Rosmond R, Dallman MF, Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 1998; 83(6): 1853-9.
195. Rosmond R, Lapidus L, Bjorntorp P. The influence of occupational and social factors on obesity and body fat distribution in middle-aged men. Int J Obes Relat Metab Disord 1996; 20(7): 599-607.
196. Rosmond R, Bjorntorp P. Psychosocial and socio-economic factors in women and their relationship to obesity and regional body fat distribution. Int J Obes Relat Metab Disord 1999; 23(2): 138-45.
197. Banegas JR, Rodriguez-Artalejo F, de la Cruz Troca JJ, Guallar-Castillon P, del Rey Calero J. Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension 1998; 32(6): 998-1002.
198. Bjorntorp P, Holm G, Rosmond R, Folkow B. Hypertension and the metabolic syndrome: closely related central origin? Blood Press 2000; 9(2-3): 71-82.
199. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992; 35(7): 595-601.
200. Leon DA, Lithell HO, Vagero D, Koupilova I, Mohsen R, Berglund L, et al. Reduced fetal growth rate and increased risk of death from ischaemic heart disease: cohort study of 15 000 Swedish men and women born 1915-29. BMJ 1998; 317(7153): 241-5.
201. Barker DJP. Fetal Origins of Cardiovascular and Lung Disease. !st ed. New York: Dekker; 2001.
202. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Ascherio AL, Stampfer MJ. Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation 1996; 94(12): 3246-50.
203. Barker DJ, Eriksson JG, Forsen T, Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 2002; 31(6): 1235-9.
204. Gluckman PD, Hanson MA. Living with the past: evolution, development, and patterns of disease. Science 2004; 305(5691): 1733-6.
205. Drake AJ, Walker BR. The intergenerational effects of fetal programming: non-genomic mechanisms for the inheritance of low birth weight and cardiovascular risk. J Endocrinol 2004; 180(1): 1-16.
206. Langley-Evans SC, Welham SJ, Jackson AA. Fetal exposure to a maternal low protein diet impairs nephrogenesis and promotes hypertension in the rat. Life Sci 1999; 64(11): 965-74.
207. Ozanne SE, Olsen GS, Hansen LL, Tingey KJ, Nave BT, Wang CL, et al. Early growth restriction leads to down regulation of protein kinase C zeta and insulin resistance in skeletal muscle. J Endocrinol 2003; 177(2): 235-41.
208. Brawley L, Torrens C, Anthony FW, Itoh S, Wheeler T, Jackson AA, et al. Glycine rectifies vascular dysfunction induced by dietary protein imbalance during pregnancy. J Physiol 2004; 554(Pt 2): 497-504.
209. Phillips DI, Barker DJ. Association between low birthweight and high resting pulse in adult life: is the sympathetic nervous system involved in programming the insulin resistance syndrome? Diabet Med 1997; 14(8): 673-7.
210. Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab 2000; 279(1): E83-7.
211. Norman JF, LeVeen RF. Maternal atherogenic diet in swine is protective against early atherosclerosis development in offspring consuming an atherogenic diet post-natally. Atherosclerosis 2001; 157(1): 41-7.
212. Fall CH. The fetal and early life origins of adult disease. Indian Pediatr 2003; 40(5): 480-502.
213. Neel JV. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 1962; 14: 353-62.
214. Eriksson JG, Lindi V, Uusitupa M, Forsen TJ, Laakso M, Osmond C, et al. The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth. Diabetes 2002; 51(7): 2321-4.
215. Johnson RJ, Titte S, Cade JR, Rideout BA, Oliver WJ. Uric acid, evolution and primitive cultures. Semin Nephrol 2005; 25(1): 3-8.
216. Watanabe S, Kang DH, Feng L, Nakagawa T, Kanellis J, Lan H, et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 2002; 40(3): 355-60.
217. Baschetti R. Diabetes epidemic in newly westernized populations: is it due to thrifty genes or to genetically unknown foods? J R Soc Med 1998; 91(12): 622-5.
218. Watenpaugh DE, Hargens AR. The Cardiovascular System in Microgravity. In: Bethseda MD, editor. Handbook of Physiology: American Physiological Society; 1996. pp. 631-674.
219. Harsch IA, Hahn EG, Konturek PC. Insulin resistance and other metabolic aspects of the obstructive sleep apnea syndrome. Med Sci Monit 2005; 11(3): RA70-5.
220. Pepperell JC, Davies RJ, Stradling JR. Systemic hypertension and obstructive sleep apnoea. Sleep Med Rev 2002; 6(3): 157-73.
221. Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997; 157(15): 1746-52.
222. Cheshire K, Engleman H, Deary I, Shapiro C, Douglas NJ. Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome. Arch Intern Med 1992; 152(3): 538-41.
223. Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Annu Rev Med 1976; 27: 465-84.
224. Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998; 98(8): 772-6.
225. Levinson PD, Millman RP. Causes and consequences of blood pressure alterations in obstructive sleep apnea. Arch Intern Med 1991; 151(3): 455-62.
226. Obstructive sleep apnea and blood pressure elevation: what is the relationship? Working Group on OSA and Hypertension. Blood Press 1993; 2(3): 166-82.
227. O'Donnell CP, King ED, Schwartz AR, Smith PL, Robotham JL. Effect of sleep deprivation on responses to airway obstruction in the sleeping dog. J Appl Physiol 1994; 77(4): 1811-8.
228. Fletcher EC, Lesske J, Qian W, Miller CC, 3rd, Unger T. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 1992; 19(6 Pt 1): 555-61.
229. Fletcher EC, Lesske J, Behm R, Miller CC, 3rd, Stauss H, Unger T. Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. J Appl Physiol 1992; 72(5): 1978-84.
230. Brooks D, Horner RL, Kimoff RJ, Kozar LF, Render-Teixeira CL, Phillipson EA. Effect of obstructive sleep apnea versus sleep fragmentation on responses to airway occlusion. Am J Respir Crit Care Med 1997; 155(5): 1609-17.
231. Buckley TM, Schatzberg AF. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 2005; 90(5): 3106-14.
232. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002; 359(9302): 204-10.
233. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165(5): 670-6.
234. Harsch IA, Schahin SP, Radespiel-Troger M, Weintz O, Jahreiss H, Fuchs FS, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 169(2): 156-62.
235. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107(8): 1129-34.
236. Marik PE. Leptin, obesity, and obstructive sleep apnea. Chest 2000; 118(3): 569-71.